Back to results
US 5,958,442 AGranted
Oncostatin M for treating inflammation
AssigneeBristol-Myers Squibb Company
InventorsPhilip M. Wallace, Thomas J. Brown
Life of this patent
Estimating the term…
Abstract
Oncostatin M is employed in methods to treat acute and chronic gastrointestinal inflammation, rheumatoid arthritis and multiple sclerosis.
Claims12
A method for inhibiting gastrointestinal inflammation in a mammalian host comprising administering to the host a gastrointestinal inflammation-inhibiting amount of Oncostatin M.
Dependencies are inferred from the claim text.